» Articles » PMID: 28379344

A Score Model to Predict Risk of Events in Patients with Brugada Syndrome

Abstract

Aims: Risk stratification in Brugada Syndrome (BS) remains challenging. Arrhythmic events can occur life-long and studies with long follow-ups are sparse. The aim of our study was to investigate long-term prognosis and risk stratification of BS patients.

Methods And Results: A single centre consecutive cohort of 400 BS patients was included and analysed. Mean age was 41.1 years, 78 patients (19.5%) had a spontaneous type I electrocardiogram (ECG). Clinical presentation was aborted sudden cardiac death (SCD) in 20 patients (5.0%), syncope in 111 (27.8%) and asymptomatic in 269 (67.3%). Familial antecedents of SCD were found in 184 individuals (46.0%), in 31 (7.8%) occurred in first-degree relatives younger than 35 years. An implantable cardioverter defibrillator (ICD) was placed in 176 (44.0%). During a mean follow-up of 80.7 months, 34 arrhythmic events occurred (event rate: 1.4% year). Variables significantly associated to events were: presentation as aborted SCD (Hazard risk [HR] 20.0), syncope (HR 3.7), spontaneous type I (HR 2.7), male gender (HR 2.7), early SCD in first-degree relatives (HR 2.9), SND (HR 5.0), inducible VA (HR 4.7) and proband status (HR 2.1). A score including ECG pattern, early familial SCD antecedents, inducible electrophysiological study, presentation as syncope or as aborted SCD and SND had a predictive performance of 0.82. A score greater than 2 conferred a 5-year event probability of 9.2%.

Conclusions: BS patients remain at risk many years after diagnosis. Early SCD in first-degree relatives and SND are risk factors for arrhythmic events. A simple risk score might help in the stratification and management of BS patients.

Citing Articles

Paroxysmal, Persistent, and Permanent Type-1 Brugada Pattern: Does Burden Matter?.

Yinadsawaphan T, Rattanawong P, Kulthamrongsri N, Shen W, Sorajja D J Cardiovasc Dev Dis. 2025; 12(2).

PMID: 39997499 PMC: 11855952. DOI: 10.3390/jcdd12020065.


A Vision Transformer Model for the Prediction of Fatal Arrhythmic Events in Patients with Brugada Syndrome.

Randazzo V, Caligari S, Pasero E, Giustetto C, Saglietto A, Bertarello W Sensors (Basel). 2025; 25(3).

PMID: 39943462 PMC: 11820670. DOI: 10.3390/s25030824.


SCN5A variant type-dependent risk prediction in Brugada syndrome.

Aizawa T, Makiyama T, Huang H, Imamura T, Fukuyama M, Sonoda K Europace. 2025; 27(2).

PMID: 39931825 PMC: 11844247. DOI: 10.1093/europace/euaf024.


Asymptomatic Brugada syndrome: Navigating implantable cardioverter-defibrillator implantation dilemma.

Lima M, Almeida A, Matos D, Cavaco D, Adragao P HeartRhythm Case Rep. 2025; 10(12):941-945.

PMID: 39897681 PMC: 11781890. DOI: 10.1016/j.hrcr.2024.09.008.


Epicardial Ablation for Arrhythmogenic Disorders in Patients with Brugada Syndrome.

Matteucci A, Mariani M, Sgarra L, Bonanni M, Frazzetto M, La Fazia V Biomedicines. 2025; 13(1).

PMID: 39857610 PMC: 11762830. DOI: 10.3390/biomedicines13010027.